News Med comms agency 90TEN acquired by Envision Pharma Group 90TEN has been acquired by Envision Pharma Group in a move its new parent company says will deepen and diversify its offering.
News Hanover Health combines London public affairs and comms prac... Hanover Health has restructured its London business, bringing its public affairs and communications practices together.
News NICE backs first targeted therapy for ALK+ lung cancer Roche's Alecensa has been recommended for routine NHS use as an adjuvant treatment for ALK-positive non-small cell lung cancer (NSCLC), the first targeted therapy for this indication.
Sales & Marketing Sponsored Global reach, personal touch: Mastering customer engagement ... In today's interconnected pharma market, the ability to scale engagement across borders is essential for survival and growth.